Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
Perucca
E
E
Marchioni
E
E
Soragna
D
D
Savoldi
F
F
D000368:Aged; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism*; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology*; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D011619:Psychotropic Drugs / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics
D019389:Cytochrome P-450 CYP2D6; D005473:Fluoxetine; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors